Adverum Biotechnologies
(NASDAQ:ADVM)
$0.6408
At close: Dec 6(Delayed 15-Minutes)
Get Real Time Here
$0.6408
PreMarket: 4:00PM EDT
Day Range- - -52 Wk Range0.630 - 2.040Open / Close- / -Float / Outstanding87.746M / 99.729M
Vol / Avg.0 / 497.077KMkt Cap63.906MP/E-50d Avg. Price0.830
Div / Yield (Forward)- / -%Payout Ratio-Total Float87.746MEPS-1.580

Adverum Biotechnologies Stock (NASDAQ:ADVM), Quotes and News Summary

Adverum Biotechnologies Stock (NASDAQ: ADVM) stock price, news, charts, stock research, profile.

Loading...
Day Range- - -52 Wk Range0.630 - 2.040Open / Close- / -Float / Outstanding87.746M / 99.729M
Vol / Avg.0 / 497.077KMkt Cap63.906MP/E-50d Avg. Price0.830
Div / Yield (Forward)- / -%Payout Ratio-Total Float87.746MEPS-1.580
Seeking Alpha - Feb 7, 2022, 4:16PM
InvestorsObserver - Jan 12, 2022, 6:12AM
Sector: Health Care.Industry: Biotechnology
Adverum Biotechnologies Inc is a U.S.-based clinical-stage gene therapy company. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company primarily generates revenue through license, research and collaboration arrangements with its strategic partners. Its lead product candidate is ADVM-022 which is a single, in-office intravitreal (IVT) injection gene therapy designed to deliver long-term durable levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with frequent anti-vascular endothelial growth factor (VEGF) injections.

Earnings

see more
Q3 2022Est.ActualSurprise
EPS-0.340-0.400 -0.0600
REV0
Q2 2022Est.ActualSurprise
EPS-0.340-0.440 -0.1000
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Adverum Biotechnologies (ADVM) stock?

A

You can purchase shares of Adverum Biotechnologies (NASDAQ: ADVM) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Adverum Biotechnologies's (ADVM) competitors?

Q

What is the target price for Adverum Biotechnologies (ADVM) stock?

A

The latest price target for Adverum Biotechnologies (NASDAQ: ADVM) was reported by Chardan Capital on Friday, November 11, 2022. The analyst firm set a price target for 2.00 expecting ADVM to rise to within 12 months (a possible 212.11% upside). 4 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Adverum Biotechnologies (ADVM)?

A

The stock price for Adverum Biotechnologies (NASDAQ: ADVM) is $0.6408 last updated December 6, 2022, 9:00 PM UTC.

Q

Does Adverum Biotechnologies (ADVM) pay a dividend?

A

There are no upcoming dividends for Adverum Biotechnologies.

Q

When is Adverum Biotechnologies (NASDAQ:ADVM) reporting earnings?

A

Adverum Biotechnologies’s Q3 earnings are confirmed for Thursday, November 10, 2022.

Q

Is Adverum Biotechnologies (ADVM) going to split?

A

There is no upcoming split for Adverum Biotechnologies.

Q

What sector and industry does Adverum Biotechnologies (ADVM) operate in?

A

Adverum Biotechnologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.